Skip to main content
CSL Behring News)

Global Newsroom

Recent News Releases


Coronavirus Information

During the COVID-19 outbreak, CSL is here for our patients and our larger world community.

Ukraine Information

CSL condemns the invasion of Ukraine and we are supporting multiple humanitarian relief efforts to help those impacted by this unjust act.

Latest CSL News

Latest CSL News

CSL RAI Awardees Announced

27 Sep 2022

CSL Extends Reach of Global Research Acceleration Initiative with Freshly Inked Partnerships to Fast-Track Research Programs

Bernadette Murdoch to lead CSL's Reputation CoE

14 Sep 2022

Bernadette Murdoch, an experienced Australian and global corporate affairs and communications leader across multiple industries, will join CSL and lead its global Reputation Management Center of Excellence (CoE).

CSL presents new research and development center in Marburg, Germany

13 Sep 2022

The new facility, once fully open later this calendar year, will be CSL’s largest R&D site under one roof, with more than 500 team members working in a state-of-the-art facility offering access to promising scientific partners and talent.

CSL Announces Positive Results for Garadacimab

17 Aug 2022

CSL is on track to file for regulatory approvals at end of current fiscal year and will present full data set at an upcoming scientific congress

CSL Announces Carbon Targets

17 Aug 2022

CSL advances its vision for a more sustainable future by setting new, tangible targets for carbon emissions reductions

CSL launches new brand identity

11 Aug 2022

Global biotech leader CSL today announced that all business units will be united as one family under the CSL global brand.

COVID-19 Update

24 Jun 2022

CSL continues to provide medicines to patients around the world.

CSL Welcomes US Court Ruling

11 May 2022

Statement attributable to Greg Boss, Executive Vice President - Legal, and CSL Limited Group General Counsel.

CSL recognised in AFR Best Places to Work.

26 Apr 2022

CSL ranked fourth on the Health Industry list, from a total of more than 750 organisations nominated in all sectors across Australia and New Zealand.

FDA Clearance of Plasma Collection Technology

11 Mar 2022

CSL Plasma U.S. collection centers are preparing to undergo implementation of newly cleared Rika Plasma Donation System, with limited market release beginning in Colorado centers.

Forbes Ranks CSL Among America's Best Employers

02 Mar 2022

With 25,000 global employees, CSL is one of 500 Large Employers recognized across 25 industry sectors

CSL Publishes Vifor Offer Prospectus

18 Jan 2022

CSL Behring AG Publishes Offer Prospectus On Public Tender Offer For All Publicly Held Shares Of Vifor Pharma Ltd.

CSL Joins StartX Community

30 Nov 2021

Through the StartX partnership, CSL will access an ecosystem of early stage biotech, medtech and digital healthcare ventures, exploring opportunities to collaborate around disruptive technologies and build relationships with entrepreneurial founders.

CSL Committed to AZ COVID Vaccine

14 Oct 2021

CSL Reaffirms Commitment to Manufacture AstraZeneca COVID Vaccine into 2022

Media Contacts

Australian Media Contact

CSL Limited
Mobile: +61 0450 909 211
Email: (non-urgent enquires)

News & Press Release Archive